A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment Group and the Mayo Clinic.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples